针对NF-κB的诱寡核酸:对于炎症性疾病来说,这是一个有前途的治疗方法
Maryam Mahjoubin-Tehran1, Samaneh Rezaei2, Alexandra E Butler3
1School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
概括
核因子-kappa B (NF-κB) 诱寡核酸通过抑制炎症途径提供了一个有前途的治疗策略. 这些诱通过准NF-κB激活,显示出治疗各种疾病的潜力.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 核因子-kappa B (NF-κB) 是一个转录因子,对细胞过程和炎症媒介的产生至关重要.
- 异常NF-κB激活与许多疾病的病理生理学有关,需要针对性的治疗干预.
研究的目的:
- 探索诱寡核酸 (诱ON) 在对抗NF-κB介导疾病方面的治疗潜力.
- 审查NF-κB诱的化学修饰和传递技术的进展.
主要方法:
- 诱惑性寡核酸 (诱惑性ON) 旨在专门抑制NF-κB激活.
- 实验室研究表明增强的放射敏感性和药物敏感性,以及阻断IL-6和IL-8基因表达.
- 在体内研究评估对动脉样硬化斑块,亚托皮炎和心脏移植存活率的影响.
主要成果:
- 在临床前模型中,NF-κB诱显示出有效性,减少炎症和改善疾病结果.
- 研究强调了改性寡核酸和新型诱设计的潜力,例如基于PNA的诱.
结论:
- NF-κB诱寡核酸是治疗炎症疾病的可行药理方法.
- 通过化学修饰和先进的传递系统克服挑战是临床翻译的关键.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107
Co-activators and Co-repressors
7.2K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.2K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
Eukaryotic Transcription Inhibitors
9.7K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.7K


